Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine. - Wikidata - awgldk - TriplyDB

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

http://www.wikidata.org/entity/Q33912706

about

Current understanding of interactions between nanoparticles and the immune system Improving the clinical impact of biomaterials in cancer immunotherapy.Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model.Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects.Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens Differential efficacy of DOTAP enantiomers for siRNA delivery in vitro Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Nanomaterials for cancer immunotherapy.

P2860

Q26345204-66C75B82-89BC-43A1-AFB5-C96AB4F3B98A Q26766267-11484A38-2F6E-48A7-BD6E-96D5280466C8 Q35739956-0F5D9AB2-B27D-41BB-BB4D-B26714C8E480 Q35786517-AFB80897-CEB7-43F6-894B-14D65ED52503 Q35812875-091A95BD-2B81-469A-9671-0AA1335F7CA5 Q36418410-0F2CDCE4-0D3C-442D-82D6-5D56DD9AD76A Q36968187-0FFC6550-4F16-4A32-A762-D47A68FDFDBE Q37731681-43F9639C-D764-4A9B-A1A2-FB5F25B58F47 Q38028994-19C0D36F-926B-47D7-B56E-27127A44FD87 Q38494470-587CF515-452B-44F8-8C0B-E2E776A7B08C Q48646732-27F6965F-3C6C-4242-9ED5-B7778EB709AD

P2860

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

http://www.wikidata.org/entity/Q33912706

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@ast

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@en

type

label

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@ast

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@en

prefLabel

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@ast

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@en

P1433

Q33912706-E39CFA3D-0FE2-47AC-B87D-76AB62213E54

P1476

Q33912706-0541318C-BA17-4FCA-A54B-763440EAD7CF

P2093

Q33912706-4D7B3CD2-A000-4E37-A022-85AF1EF2692A

Q33912706-66E0C3A1-A66E-49BC-98CF-EA0AD1386D32

Q33912706-A390E314-A744-491A-9224-0D78AAD8B1A8

P2860

Q33912706-151FBE3D-C37D-4DEA-AA54-F4C0B6C6263A

Q33912706-2B0DFA5E-530C-473F-9026-56F2D9043B8A

Q33912706-30DA28CF-F978-41EE-93DF-10711CD55C3E

Q33912706-499F78E2-F009-4934-AD00-85E6AC964CAD

Q33912706-56B51651-18A8-4685-A826-D9946F176433

Q33912706-66715403-8F80-4A82-B328-05F4671B687F

Q33912706-6A77882D-DFE7-48D6-AD94-09B232F419D2

Q33912706-7D067051-BFCE-46F3-BC6D-74AF8A6B70E8

Q33912706-90E5C02D-C719-45AA-9397-EA12BD5C4B19

Q33912706-9DC8B693-463F-453B-AD77-B82F8CB549B1

P2888

Q33912706-69BFD49F-5066-4898-B18D-BAC873F1B7DA

P304

Q33912706-384C55A8-A215-4085-B948-4BC8AC3DDB01

P31

Q33912706-B0D7A4C0-901B-427E-BA36-DC61F532EA13

P356

Q33912706-C1E0C2B8-6C69-4E7C-92D0-C18933FC8202

P433

Q33912706-85857D1E-51AC-468B-8843-4617B6CA6B2F

P478

Q33912706-4208B7D3-84D3-45E0-9E97-77CB7CA8A518

P577

Q33912706-0307DD76-99EC-4AE9-B454-76FF48E8130D

P6179

Q33912706-EA059312-FDAF-4ACC-8648-3BE0E720A8B9

P698

Q33912706-60F5EC82-4DCA-4616-B08A-B43F82904618

P932

Q33912706-CB965D9F-23A2-4A5C-95FB-60742005BD20

P356

S00262-011-0970-1

P1433

Cancer Immunology, Immunotherapy

P1476

Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.

@en

P2093

Elizabeth A Vasievich

http://www.w3.org/2001/XMLSchema#string

Leaf Huang

http://www.w3.org/2001/XMLSchema#string

Weihsu Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines against human carcinomas: strategies to improve antitumor immune responses.

Enantioselective chromatography as a powerful alternative for the preparation of drug enantiomers.

Antigen recognition: in vitro studies on the specificity of the cellular immune response

Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine.

On chiral drug action.

Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines.

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

P2888

s00262-011-0970-1

P304

629-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-011-0970-1

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046595683

http://www.w3.org/2001/XMLSchema#string

P698

21267720

http://www.w3.org/2001/XMLSchema#string

P932

5514367

http://www.w3.org/2001/XMLSchema#string